THE Therapeutic Goods Administration has posted details of application pathways and data requirements for registration of new generic medicines in the inhaler and nasal spray class.
The guidance covers prescription metered-dose asthma inhalers and nasal corticosteroids - visit tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 May 18
